Ambrisentan in Pulmonary Arterial Hypertension Efficacy Study 1 and 2 - ARIES 1 and 2

Description:

The goal of the two trials was to evaluate the safety and efficacy of ambrisentan in patients with pulmonary arterial hypertension (PAH).